top of page
schreiben.webp

20.02.2024
SAVE THE DATE: Mastocytosis Patient Day at the University Hospital Basel
On Thursday, October 24, between 5:00 p.m. and 7:00 p.m., the annual Patient Day of the Swiss Mastocytosis Network will take place at the Center for Research and Teaching (Zentrum für Lehre und Forschung) at the University Hospital Basel. 
Further information will follow.

20.02.2024
Patient inclusion in the SUMMIT study at the University Hospital Basel
SUMMIT investigates the KIT-specific tyrosine kinase inhibitor bezuclastinib (CGT9486) in patients with non-advanced systemic mastocytosis (indolent systemic mastocytosis, smoldering systemic mastocytosis, and isolated bone marrow mastocytosis). 
If you or one of your patients is interested in participating in this study, please contact us at
swiss-mastocytosis@usb.ch or via our contact form.

22.01.2024
AYVAKIT® (avapritinib) receives EMA approval Ayvakit (avapritinib) receives EMA approval for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment.

24.10.2023

Patient inclusion in the Apex study at the University Hospital Basel

APEX investigates the KIT-specific tyrosine kinase inhibitor bezuclastinib (CGT9486) as a single agent in patients with advanced systemic mastocytosis (aggressive systemic mastocytosis, systemic mastocytosis with associated hematologic neoplasia, and mast cell leukemia).

If you or one of your patients is interested in participating in this study, please contact us at swiss-mastocytosis@usb.ch or via our contact form.

12.07.2023

HOPOS Patient Day

On November 4, 2023, the HOPOS Patient Day will take place in Zurich. At this event, medical doctor Axel Rüfer from the Lucerne Cantonal Hospital will give a lecture on mastocytosis.

For further information on the HOPOS Patient Day:

https://www.hopos.ch/de/aktuelles/meldungen/2023-11-04-HOPOS-Patiententag-2023.php

11.07.2023
AYVAKIT® (Avapritinib) receives FDA approval for indolent systemic mastocytosis in the US

Past events 

11.07.2023

ECNM Meeting

The 21st annual meeting of the European Competence Network on Mastocytosis (ECNM) will take place from September 21 -23, 2023 in Antwerp, Belgium.

Further information on this meeting can be found at: https://ecnm-conference.com/

bottom of page